Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease
2011
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes
2007
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy
2011
Acute kidney injury
2012 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Proportionate and Disproportionate Functional Mitral Regurgitation
2018
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Acute Phosphodiesterase 5 Inhibition Mimics Hemodynamic Effects of B-Type Natriuretic Peptide and Potentiates B-Type Natriuretic Peptide Effects in Failing But Not Normal Canine Heart
2007
Impaired right ventricular function in adenotonsillar hypertrophy
2007
B-type natriuretic peptide levels: A potential novel “white count” for congestive heart failure
2001
Acute Cardiac Tamponade
2003 Standout
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension
2004
Comparison of Estimates of Right Atrial Pressure by Physical Examination and Echocardiography in Patients With Congestive Heart Failure and Reasons for Discrepancies
1997
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart
2003
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
2015
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin
2001
Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death
2004 StandoutNobel
Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community
2006
Defining “Severe” Secondary Mitral Regurgitation
2014
An Alternative Echocardiographic Method to Estimate Mean Pulmonary Artery Pressure: Diagnostic and Clinical Implications
2009
Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea
2002
Hormones and Hemodynamics in Heart Failure
1999
Molecular mechanism of cGMP-mediated smooth muscle relaxation
2000
Diagnosis and differential assessment of pulmonary arterial hypertension
2004
Nongeometric quantitative assessment of right and left ventricular function: Myocardial performance index in normal children and patients with Ebstein anomaly
1998
Echocardiographic evaluation of pulmonary artery pressure with clinical correlates in predominantly obese adults
2002
Cardiorenal Syndrome
2008 Standout
Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure
2001 Standout
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study
2001 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
2005
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis
2007
Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene
2005 StandoutNobel
Biomarkers in Acute Cardiac Disease
2006
Natriuretic peptides in the pathophysiology of congestive heart failure
2000
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease
2010
Increased Activity of cGMP-Specific Phosphodiesterase (PDE5) Contributes to Resistance to Atrial Natriuretic Peptide Natriuresis in the Pregnant Rat
2004
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Third Universal Definition of Myocardial Infarction
2012 Standout
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Echocardiographic Indexes for the Non-Invasive Evaluation of Pulmonary Hemodynamics
2010
Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
2001
Endothelins: Pathophysiology and treatment implications in chronic heart failure
2005
Biomarkers in Heart Failure
2008 Standout
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
2003 Standout
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Enhancement of Rho/Rho-kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure
2001
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction
2007
A new model of congestive heart failure in the mouse due to chronic volume overload
2001
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Mice Lacking Endothelial ACE
2003 StandoutNobel
Hydrops Fetalis, Cardiovascular Defects, and Embryonic Lethality in Mice Lacking the Calcitonin Receptor-Like Receptor Gene
2006 StandoutNobel
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation
2017
Cardiac Hormones as Diagnostic Tools in Heart Failure
2003
Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress
2000 Standout
The Cardiac Renin-Angiotensin System
1999
Load Versus Humoral Activation in the Genesis of Early Hypertensive Heart Disease
2001
Endothelial Dysfunction in Chronic Myocardial Infarction Despite Increased Vascular Endothelial Nitric Oxide Synthase and Soluble Guanylate Cyclase Expression
1999
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
B-Type Natriuretic Peptide in Organic Mitral Regurgitation
2005
Works of Daniel D. Borgeson being referenced
Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure
2005
Mitral regurgitation in patients with advanced systolic heart failure
2004
Blunted cGMP response to agonists and enhanced glomerular cyclic 3′,5′-nucleotide phosphodiesterase activities in experimental congestive heart failure
1996
Frequency of Doppler measurable pulmonary artery pressures
1996
Relationship between left ventricular wall stress and ANP gene expression during the evolution of rapid ventricular pacing‐induced heart failure in the dog
2000
Biomarker Responses during and after Treatment with Nesiritide Infusion in Patients with Decompensated Chronic Heart Failure
2004
Safety and efficacy of an orally active selective endothelin—A receptor antagonist in moderate-severe human chronic heart failure
1999
BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure
1997
Adrenomedullin in experimental congestive heart failure: cardiorenal activation
1997
Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
1998
Angiotensin II in the Evolution of Experimental Heart Failure
1996